Cite
HARVARD Citation
Shigesawa, T. et al. (2020). Baseline angiopoietin‐2 and FGF19 levels predict treatment response in patients receiving multikinase inhibitors for hepatocellular carcinoma. JGH open. 4 (5), pp. 880-888. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Shigesawa, T. et al. (2020). Baseline angiopoietin‐2 and FGF19 levels predict treatment response in patients receiving multikinase inhibitors for hepatocellular carcinoma. JGH open. 4 (5), pp. 880-888. [Online].